Meet with NCI SBIR to Learn About New Funding & Resources for Early-Stage Companies
The National Cancer Institute Small Business Innovation Research Development Center invites you to attend upcoming events in the San Francisco Bay Area to learn about new non-dilutive funding opportunities available for early-stage companies. These sessions will cover current and upcoming changes to the SBIR & STTR programs, practical strategies for developing successful proposals, and other NCI resources offered to accelerate drug development and commercialization.
Funding for Early-Stage Ventures from the National Cancer Institute
July 30, 2013
1:00 p.m. – 2:30 p.m. (PDT)
Entrepreneurship Center at UCSF
Rock Hall Auditorium, Mission Bay
San Francisco, CA
Michael Weingarten, Director of the NCI SBIR Development Center, and Jennifer Shieh, AAAS Science & Technology Policy Fellow, will be at UCSF’s Mission Bay campus to present and discuss the SBIR and STTR programs that fund and support small biomedical technology companies. Click here to register.
This session will provide an overview of:
- The SBIR & STTR programs and current funding opportunities for innovative biomedical technology.
- Recent policy changes that expand program eligibility to venture capital backed companies.
- Practical strategies and tips for developing successful and competitive proposals.
Opportunities for one-on-one meetings with Michael and Jennifer are available for attendees following the presentation. If interested in scheduling a one-on-one meeting, please send a one page overview or executive summary to firstname.lastname@example.org by July 22.
1:00 p.m. – 2:30 p.m. Presentations and Q&A
3:00 p.m. – 6:00 p.m. One-on-One Meetings
Registration is free for California Institute for Quantitative Biosciences (UCSF/QB3) affiliates and $20.00 for all others interested in attending. Please click here to register for this event.
TTS North America 2013
July 29 – 30, 2013
UCSF Mission Bay
San Francisco, CA
TTS North America brings together the community of leading technology transfer, licensing, IP, and early stage biotech innovation and venture professionals worldwide. With open discussions and debates on best practices, lessons learned, and issues like negotiation and strategic industry-research collaborations, the TTS is a key platform and meeting place for tech transfer offices to meet with and understand their counterparts from industry.
NCI SBIR Development Center Director Michael Weingarten will be giving the keynote address at TTS North America 2013 on Monday, July 29. He will also be a panelist on Financing Innovation.
For more information and to register, click here.
We hope you and your colleagues will join us to discover how working with the NCI SBIR Development Center can catalyze small business innovation and the commercialization of cancer technologies. Be sure to continue to check the website for updates and events. For a full list of funding opportunities currently available from the NCI SBIR & STTR Programs, please click here.
The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.